On the one hand, data support a role of ICOS:ICOSL in facilitating the anti-tumor T cell response because of observations that diminished ICOS levels in blood associate with worse prognosis in colon cancer and that high ICOS expression on tumor-infiltrating lymphocytes in metastatic melanoma lesions was associated with better post-recurrence survival. The gene discussed is ICOS; the disease is neoplasm.